Block Listing Interim Review

Source: RNS
RNS Number : 6513U
Allergy Therapeutics PLC
02 August 2022
 

Allergy Therapeutics plc

Block Listing Interim Review

 

 

Date 2 August 2022

 

Name of applicant:

ALLERGY THERAPEUTICS PLC

Name of scheme:

Allergy Therapeutics plc 2013 Long Term Incentive Plan 

Period of return:

From:

1 February 2022

To:

31 July 2022

Number and class of share(s) (amount of stock / debt securities) originally listed and the date of admission:

10,000,000 ordinary shares of 0.1p each in the Company admitted to trading on 24 November 2017

Balance of unallotted securities under scheme(s) from previous return:

7,118,772

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

0

Less:  Number of securities issued/allotted under scheme(s) during period:

0

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

7,118,772

 

Name of contact:

Sara Goldsbrough

Telephone number of contact:

+44 (0) 7966 165719 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BLREAFPAESKAEFA